Clinical trials for Lymphoma
94 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Lymphoma
CLL & Richter's syndrome
#NCT06564038
#2024-515034-33-00
B cell lymphoma
CLL (Chronic Lymphocytic Leukemia)
Lymphocytic lymphoma
1
2
3 or more
Targeted therapy
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT06564038
#2024-515034-33-00
Cohorte 2A et 2C
B cell lymphoma
Mantel cell lymphoma
Early (stage I and II)
Disseminated (stage III and IV)
2
3 or more
Targeted therapy
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT06564038
#2024-515034-33-00
Cohorte 3A Lymphomes B non hodgkinien R/R
B cell lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
MALT lymphoma
Lymphocytic lymphoma
Indolent transformed lymphoma
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT06564038
#2024-515034-33-00
Cohortes 3A et 3B Lymphome à grandes cellules B
B cell lymphoma
Large B cell lymphoma
None
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
CLL & Richter's syndrome
#NCT06564038
#2024-515034-33-00
Cohorte 1A et 1C
B cell lymphoma
CLL (Chronic Lymphocytic Leukemia)
Lymphocytic lymphoma
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT06137144
Module 1 Cohorte 1
Hodgkin lymphoma
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT06137144
Module 1 Cohorte 2
Hodgkin lymphoma
Disseminated (stage III and IV)
None
Chemotherapy
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT06137144
Module 2 Cohorte 1
Hodgkin lymphoma
1
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT06137144
Module 1 Cohorte 3
T cell lymphoma
Peripheral T cell lymphoma
Disseminated (stage III and IV)
1
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Lymphoma
#NCT05475925
Escalade de dose (partie A) et Extension de dose (partie B) cohorte B2
T cell lymphoma
Peripheral T cell lymphoma
Cutaneous T-cell lymphoma
Disseminated (stage III and IV)
None
Treated / Controled
1
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
Dren Bio